July 21, 2017
Brand to be re-launched in Canada by Fall 2017
Odan Laboratories (Odan) announced that it has entered on the 4th of April 2017 into a definitive agreement to acquire the branding rights for Uremol® products in Canada from GSK Consumer Healthcare (GSK) and will be re-introducing the two products to the Canadian market soon.
Howard Kaminsky, President of Odan, commented With the acquisition of the branding rights for Uremol® products, the opportunity strengthens our consumer healthcare portfolio in Canada. Odan will become the leader in urea-based products.
The Uremol® brand consists of creams and lotions containing either 10% or 20% urea. Uremol® quickly moisturizes and relieves itchy, extra dry skin.
About GSK Consumer Healthcare
GSK Consumer Healthcare is one of the world’s largest over-the-counter consumer healthcare products companies. Its more than 30 well-known brands include Voltaren® Emulgel®, Aquafresh®, Sensodyne®, and TUMS® – which are trademarks owned by and/or licensed to GlaxoSmithKline Group of Companies. These brands are successful in over 100 countries around the world because they all show our passion for quality, guaranteed by science. They are inspired by the real wants and needs of the millions of people who walk into pharmacies, supermarkets, market stalls and go on-line all over the world every day, and choose us first. Our goal is to build a global, growing business we call a Fast Moving Consumer Healthcare (FMCH) company, dedicated to everyday healthcare with all of the scientific expertise and quality guarantees that demands, working at the speed and with the genuine consumer understanding the modern world expects.
GlaxoSmithKline– one of the world’s leading research-based pharmaceutical and healthcare companies– is committed to improving the quality of human life by enabling people to do more, feel better and live longer. For company information visit: http://www.gsk.com.
Odan Laboratories is an independent, privately-owned pharmaceutical company founded in 1974 in Montréal, Québec, Canada. Through its fully integrated R&D and manufacturing capabilities, as well as through key partnerships, Odan is growing strategically with a focus on specialty generic, niche, single-source, high-entry barrier and OTC products. For more information about Odan Laboratories please visit the company’s web site at www.https://odanlab.com.
Tel: (514)448-4901 #2293
Contact GSK Consumer Healthcare
External Communications Manager, North America Communications